Burnham set to ditch Palantir from NHS data deal in major early test of premiership. n1
Andy Burnham Faces Defining Early Test as Reports Suggest He Could End the NHS’s £330 Million Palantir Contract
Just weeks before he is expected to assume the office of Prime Minister, Andy Burnham is reportedly preparing to review one of the British government’s most significant technology partnerships—a decision that could reshape how the National Health Service uses artificial intelligence and data for years to come.
According to reporting by The Daily Telegraph, Burnham is considering ending the NHS’s long-term partnership with Palantir Technologies, the U.S. data analytics company whose Federated Data Platform has become a central component of England’s healthcare data infrastructure.
If confirmed, the move would represent one of the most consequential early policy decisions of Burnham’s premiership, extending far beyond procurement policy into broader debates over technology, sovereignty, artificial intelligence, public trust, and Britain’s relationship with major American technology firms.
Although no final decision has been announced, the reports suggest Burnham is reviewing the government’s overall AI strategy and believes that what aides describe as “unfettered tech boosterism” has become politically counterproductive.
The Contract Under Review
At the center of the debate is the NHS’s Federated Data Platform (FDP).
Awarded in 2023, the seven-year contract is valued at approximately £330 million and is built on Palantir’s software.
The system enables NHS organizations to combine operational information from multiple sources, allowing hospitals to better manage patient flow, theatre scheduling, waiting lists, and resource allocation.
More than half of NHS trusts in England reportedly now use the platform.
Supporters argue the technology has produced measurable improvements.
According to NHS officials involved in the programme, the platform has contributed to:
- Faster cancer referrals and diagnosis.
- More efficient use of operating theatres.
- Improved management of waiting lists.
- Quicker discharge of patients.
- Better coordination between hospitals.
For many healthcare managers, these operational improvements have become increasingly valuable as the NHS continues working through post-pandemic backlogs.
Why Critics Remain Concerned
Despite these reported benefits, Palantir’s involvement in British healthcare has remained controversial almost from the beginning.
Much of the criticism has focused on data governance.
Campaigners have questioned whether a private American technology company should play such a significant role in managing infrastructure involving sensitive NHS patient information.
Previous reports suggested that Palantir contractors received extensive access to NHS datasets during implementation.
Internal NHS documents reportedly warned that such arrangements risked undermining public confidence if not carefully managed.
Importantly, NHS officials have consistently stated that patient data remains under NHS control and that Palantir acts as a technology provider rather than the owner of medical records.
Nevertheless, concerns regarding privacy, transparency, and oversight have persisted.
Burnham’s Record in Greater Manchester
One reason these reports have attracted attention is Burnham’s record as Mayor of Greater Manchester.
According to reporting, neither the Greater Manchester Combined Authority nor Greater Manchester Police awarded Palantir contracts during his tenure.
Supporters describe that record as evidence of a consistent philosophy rather than a sudden political calculation.
Burnham has also increasingly emphasized the concept of “social value” when governments award public contracts.
In recent speeches following his return to Westminster, he argued that procurement decisions should consider broader public interests alongside price and technical capability.
That philosophy appears consistent with a wider review of Britain’s artificial intelligence strategy reportedly now underway.
Pressure From Inside Labour
Pressure to reconsider Palantir’s NHS role has grown steadily within Labour.
Critics point to the company’s commercial relationships with the Israel Defense Forces and U.S. Immigration and Customs Enforcement.
Others focus on the political views of Palantir’s leadership.
Founder Peter Thiel has long supported conservative political causes in the United States and was an early supporter of Donald Trump.
Chief Executive Alex Karp has also expressed support for Trump.
Some Labour MPs argue these associations make continued government partnerships politically and ethically problematic.
Earlier this year, more than twenty Labour MPs signed a parliamentary motion criticizing another government contract awarded to Palantir by the Ministry of Defence.
The Conservative Response
Opposition politicians argue that political disagreements should not determine healthcare technology policy.
Shadow Health Secretary Stuart Andrew warned against abandoning technology that has reportedly improved patient outcomes.
He argued that patients should remain the primary consideration and cautioned that ending the partnership for political reasons could undermine future cooperation between the NHS and global technology companies.
Supporters of Palantir similarly contend that operational performance—not the political beliefs of company executives—should guide procurement decisions.
NHS Officials Warn Against Losing Momentum
Some former NHS technology leaders have also defended the programme.
Tom Bartlett, who previously led the NHS engineering team responsible for implementing the Federated Data Platform, has argued that staff members are increasingly reluctant to speak publicly in support of the system.
According to Bartlett, concerns about political criticism have discouraged some healthcare professionals from discussing what they believe have been meaningful operational improvements.
That observation reflects a broader tension.
Many clinicians focus primarily on whether technology improves patient care.
Political leaders must simultaneously consider issues of procurement, ethics, privacy, national security, and public confidence.
A Wider Pattern Beyond Healthcare
The NHS contract is not the only Palantir agreement facing political uncertainty.
Earlier disputes involving Sadiq Khan and the Metropolitan Police Service demonstrated similar tensions.
Khan blocked a proposed £50 million police contract with Palantir.
The company responded by initiating legal proceedings, arguing the decision unfairly restricted competition.
Subsequently, London authorities approved smaller agreements involving the company while extending another existing arrangement.
Those developments illustrate how Labour politicians themselves remain divided over Palantir’s appropriate role within British public services.
Britain’s Broader AI Strategy
The reported review of the NHS contract appears connected to a much wider discussion.
Burnham has indicated that Britain should develop an industrial strategy placing greater emphasis on domestic technological capability.
Advisers reportedly believe previous efforts to cultivate close relationships with large American technology firms have produced fewer economic benefits than expected.
Instead, the emerging strategy appears likely to prioritize British innovation, regional investment, and greater public oversight of artificial intelligence.
If implemented, ending or restructuring the Palantir contract could become an early symbol of that broader policy direction.
My Professional Perspective
Having covered technology policy, government procurement, and healthcare reform for decades, I believe this story is frequently being framed too narrowly.
Many discussions portray it as a simple question:
Should Britain keep or remove Palantir?
The real issue is considerably more complicated.
This Is Really About Technological Sovereignty
The deeper debate concerns control.
Modern governments increasingly depend upon sophisticated software for healthcare, policing, taxation, defence, and public administration.
Once those systems become deeply integrated, replacing them becomes technically difficult, operationally disruptive, and financially expensive.
That phenomenon—sometimes described as vendor lock-in—is common throughout the technology industry.
Governments therefore face a difficult balance.
They want access to world-leading technology.
They also want to avoid becoming permanently dependent upon any single supplier.
That challenge exists regardless of whether the supplier is American, British, or from elsewhere.
Politics and Performance Are Pulling in Different Directions
Perhaps the most interesting feature of this debate is that political and operational arguments do not necessarily point toward the same conclusion.
Operational evidence suggests many NHS organizations have benefited from improved data coordination.
Political concerns focus on issues that extend beyond technical performance:
- Public trust.
- Data governance.
- National resilience.
- Corporate ethics.
- Industrial policy.
Both perspectives deserve consideration.
A technology platform can perform well while still generating legitimate policy concerns.
Conversely, replacing an effective operational system simply because its supplier has become politically controversial carries risks of its own.
Can Britain Build Its Own Alternative?
Burnham’s reported emphasis on supporting domestic technology raises an important strategic question.
If Britain wishes to reduce dependence on foreign technology companies, what domestic alternatives currently exist?
Developing secure, nationwide healthcare infrastructure capable of serving the NHS requires extraordinary technical expertise, substantial investment, and many years of implementation.
Replacing Palantir would therefore involve far more than terminating a contract.
It would require a credible transition strategy capable of avoiding disruption to patient care.
That challenge should not be underestimated.
Public Trust May Ultimately Decide the Issue
Healthcare differs from most government sectors because public confidence is essential.
Patients must believe their medical information is secure.
Even highly effective technology can become politically unsustainable if significant portions of the public distrust those managing sensitive health data.
For that reason, transparency may prove more important than ideology.
If governments clearly explain how data are protected, who can access information, and what safeguards exist, public confidence becomes easier to maintain.
Without that trust, even technically successful systems become vulnerable to political opposition.
The Decision Will Signal More Than Procurement Policy
Whatever Burnham ultimately decides, the decision will communicate something much broader about Britain’s future economic strategy.
Maintaining the contract would signal continuity and confidence in existing partnerships with global technology firms.
Ending it would suggest a willingness to prioritize technological sovereignty and domestic capability, even if doing so involves significant operational challenges.
Either outcome would shape perceptions of Britain’s AI strategy far beyond the NHS itself.
Conclusion
The reported review of the NHS’s £330 million Palantir contract has become one of the earliest and most closely watched policy questions facing Andy Burnham before he is expected to enter Downing Street.
Supporters of the platform argue that it has already delivered meaningful improvements in hospital efficiency and patient care. Critics counter that concerns over data governance, corporate affiliations, and Britain’s long-term technological independence justify a reassessment of the partnership.
At present, no final decision has been made. The government has described the review as part of normal contract management, and Burnham has not publicly committed to terminating the agreement.
The eventual decision will likely influence not only the future of NHS digital infrastructure but also Britain’s wider approach to artificial intelligence, public procurement, and strategic technology policy.
Ultimately, the central question extends well beyond one company:
As governments become increasingly dependent on advanced artificial intelligence systems, how should they balance technological excellence, public trust, national resilience, and democratic accountability when deciding who builds the digital infrastructure of the state?
